| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Centre for Diabetes and Endocrine Research (A.A.R., T.S., H.K.C., G.A.M., J.B.P., J.P.W.), School of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia; and Institute for Molecular Bioscience (A.J.), University of Queensland, Brisbane, Queensland 4072, Australia
Address all correspondence and requests for reprints to: Jonathan P. Whitehead, Centre for Diabetes and Endocrine Research, University of Queensland, Ground Floor, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia. E-mail: jwhitehead{at}cder.soms.uq.edu.au.
Adiponectin is a secreted, multimeric protein with insulin-sensitizing, antiatherogenic, and antiinflammatory properties. Serum adiponectin consists of trimer, hexamer, and larger high-molecular-weight (HMW) multimers, and these HMW multimers appear to be the more bioactive forms. Multimer composition of adiponectin appears to be regulated; however, the molecular mechanisms involved are unknown. We hypothesize that regulation of adiponectin multimerization and secretion occurs via changes in posttranslational modifications (PTMs). Although a structural role for intertrimer disulfide bonds in the formation of hexamers and HMW multimers is established, the role of other PTMs is unknown. PTMs identified in murine and bovine adiponectin include hydroxylation of multiple conserved proline and lysine residues and glycosylation of hydroxylysines. By mass spectrometry, we confirmed the presence of these PTMs in human adiponectin and identified three additional hydroxylations on Pro71, Pro76, and Pro95. We also investigated the role of the five modified lysines in multimer formation and secretion of recombinant human adiponectin expressed in mammalian cell lines. Mutation of modified lysines in the collagenous domain prevented formation of HMW multimers, whereas a pharmacological inhibitor of prolyl- and lysyl-hydroxylases, 2,2'-dipyridyl, inhibited formation of hexamers and HMW multimers. Bacterially expressed human adiponectin displayed a complete lack of differentially modified isoforms and failed to form bona fide trimers and larger multimers. Finally, glucose-induced increases in HMW multimer production from human adipose explants correlated with changes in the two-dimensional electrophoresis profile of adiponectin isoforms. Collectively, these data suggest that adiponectin multimer composition is affected by changes in PTM in response to physiological factors.
This article has been cited by other articles:
![]() |
E. J. Folco, V. Z. Rocha, M. Lopez-Ilasaca, and P. Libby Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10 J. Biol. Chem., September 18, 2009; 284(38): 25569 - 25575. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg and B. E. Kemp AMPK in Health and Disease Physiol Rev, July 1, 2009; 89(3): 1025 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Hendricks III, J. A. Hadley, S. M. Krzysik-Walker, K. S. Prabhu, R. Vasilatos-Younken, and R. Ramachandran Unique Profile of Chicken Adiponectin, a Predominantly Heavy Molecular Weight Multimer, and Relationship to Visceral Adiposity Endocrinology, July 1, 2009; 150(7): 3092 - 3100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banga, R. Unal, P. Tripathi, I. Pokrovskaya, R. J. Owens, P. A. Kern, and G. Ranganathan Adiponectin translation is increased by the PPAR{gamma} agonists pioglitazone and {omega}-3 fatty acids Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E480 - E489. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schegg, A. J. Hulsmeier, C. Rutschmann, C. Maag, and T. Hennet Core Glycosylation of Collagen Is Initiated by Two {beta}(1-O)Galactosyltransferases Mol. Cell. Biol., February 15, 2009; 29(4): 943 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Wong, S. A. Krawczyk, C. Kitidis-Mitrokostas, G. Ge, E. Spooner, C. Hug, R. Gimeno, and H. F. Lodish Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin FASEB J, January 1, 2009; 23(1): 241 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Teoh, A. Quan, K. W. A. Bang, G. Wang, F. Lovren, V. Vu, J. J. Haitsma, P. E. Szmitko, M. Al-Omran, C.-H. Wang, et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E658 - E664. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leth, K. K. Andersen, J. Frystyk, L. Tarnow, P. Rossing, H.-H. Parving, and A. Flyvbjerg Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3186 - 3191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saraheimo, C. Forsblom, L. Thorn, J. Waden, M. Rosengard-Barlund, O. Heikkila, K. Hietala, D. Gordin, J. Frystyk, A. Flyvbjerg, et al. Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes Diabetes Care, June 1, 2008; 31(6): 1165 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Miller, P. Siripurkpong, J. Hawes, A. Majdalawieh, H.-S. Ro, and R. S. McLeod The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPAR{gamma}-dependent and PPAR{gamma}-independent mechanisms J. Lipid Res., March 1, 2008; 49(3): 550 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chandrasekar, D. N. Patel, S. Mummidi, J.-w. Kim, R. A. Clark, and A. J. Valente Interleukin-18 Suppresses Adiponectin Expression in 3T3-L1 Adipocytes via a Novel Signal Transduction Pathway Involving ERK1/2-dependent NFATc4 Phosphorylation J. Biol. Chem., February 15, 2008; 283(7): 4200 - 4209. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sipila, H. Ruotsalainen, R. Sormunen, N. L. Baker, S. R. Lamande, M. Vapola, C. Wang, Y. Sado, A. Aszodi, and R. Myllyla Secretion and Assembly of Type IV and VI Collagens Depend on Glycosylation of Hydroxylysines J. Biol. Chem., November 16, 2007; 282(46): 33381 - 33388. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Maahs, L. G. Ogden, J. K. Snell-Bergeon, G. L. Kinney, R. P. Wadwa, J. E. Hokanson, D. Dabelea, A. Kretowski, R. H. Eckel, and M. Rewers Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes Am. J. Epidemiol., September 15, 2007; 166(6): 731 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W Peake, J. T Hughes, Y. Shen, and J. A Charlesworth Glycosylation of human adiponectin affects its conformation and stability J. Mol. Endocrinol., July 1, 2007; 39(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Simons, P. S van den Pangaart, J. M F G Aerts, and L. Boon Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization J. Endocrinol., February 1, 2007; 192(2): 289 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bodles, A. Banga, N. Rasouli, F. Ono, P. A. Kern, and R. J. Owens Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1100 - E1105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |